Compare,PMID,Parameter,Sentece,Title,Type,URL,Units,Value,id,Drugbank_id,Name
,10868311,AUC,"Extravascular administration significantly increased mean serum interferon alfa-n3 AUC values (1152 +/- 214, 944 +/- 209, and 576 +/- 188 U.h/mL, p < 0.001, with SQ, i.m., and i.v. administration, respectively) and 2-5(A) synthetase activity at 36 and 48 hours after dosing.",Extravascular administration of interferon alfa-N3 increases serum exposure and 2-5(A) synthetase activity. ,AUCinf-Q17,[Article Link](https://pubmed.ncbi.nlm.nih.gov/10868311/),[h·u] / [ml],1152,213330,DB00018,Interferon alfa-n3
,10868311,AUC,"Extravascular administration significantly increased mean serum interferon alfa-n3 AUC values (1152 +/- 214, 944 +/- 209, and 576 +/- 188 U.h/mL, p < 0.001, with SQ, i.m., and i.v. administration, respectively) and 2-5(A) synthetase activity at 36 and 48 hours after dosing.",Extravascular administration of interferon alfa-N3 increases serum exposure and 2-5(A) synthetase activity. ,AUCinf-Q17,[Article Link](https://pubmed.ncbi.nlm.nih.gov/10868311/),[h·u] / [ml],944,213331,DB00018,Interferon alfa-n3
,10868311,AUC,"Extravascular administration significantly increased mean serum interferon alfa-n3 AUC values (1152 +/- 214, 944 +/- 209, and 576 +/- 188 U.h/mL, p < 0.001, with SQ, i.m., and i.v. administration, respectively) and 2-5(A) synthetase activity at 36 and 48 hours after dosing.",Extravascular administration of interferon alfa-N3 increases serum exposure and 2-5(A) synthetase activity. ,AUCinf-Q17,[Article Link](https://pubmed.ncbi.nlm.nih.gov/10868311/),[h·u] / [ml],576,213332,DB00018,Interferon alfa-n3
